The following is a summary of the Helen of Troy Limited (HELE) Q4 2024 Earnings Call Transcript:

Financial Performance:

• Helen of Troy exceeded the full-year fiscal '24 consolidated net sales and adjusted EPS outlook.

• Gross profit margin expanded by 390 basis points.

• Generated $269 million in free cash flow, and decreased total debt to $665.7 million.

• Expects free cash flow in the range of $255 million to $275 million, and adjusted EBITDA of $324 million to $331 million for FY '25.

• Planning to make investments worth 100bps, targeting growth.

• Predicts GAAP diluted EPS of $6.68 to $7.45 for the full year.

• Anticipates capital expenditures of between $30 million and $35 million for fiscal '25.

• Expects net sales between $1.965 billion and $2.025 billion in fiscal '25, indicating a decline of 2% to growth of 1%.

Business Progress:

• Initiated Project Pegasus for strategic investments.

• Launched plans to accelerate the investment in cloud infrastructure.

• Reported progress with objectives, including global operational expansion.

• Plans to implement an expanded go-to-market structure with the North America RMO in fiscal '25.

• Expects some margin compression from the expiration of out-licensed wellness brand relationships.

• Expects robust volume growth from direct-to-consumer (DTC) platforms.

• Plans to increase investment in brand health and upscaling market share.

• Anticipates lumpy revenues due to new distribution layers going into subsequent quarters.

• Will prioritize white space distribution opportunities.

• Planned further distribution expansions for FY 2025, with successful progress noted in fiscal 2024.

• OXO Soft Works' early roll-out at Walmart as a highlight; further expansion expected throughout FY 2025.

More details: Helen Of Troy IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.